Cargando…
Matrix Metalloproteinases in Cerebral Ischemia
Matrix metalloproteinases (MMPs) are involved in the pathophysiology of several central nervous system diseases that share common pathogeneses, such as disruption of the blood-brain barrier (BBB), neuroinflammation, oxidative stress, and remodeling of the extracellular matrix (ECM). In early ischemi...
Autores principales: | Kim, Hahn Young, Han, Seol-Heui |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Korean Neurological Association
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2854960/ https://www.ncbi.nlm.nih.gov/pubmed/20396502 http://dx.doi.org/10.3988/jcn.2006.2.3.163 |
Ejemplares similares
-
Matrix Metalloproteinases and Glaucoma
por: Kim, Moo Hyun, et al.
Publicado: (2022) -
Matrix Metalloproteinases in Cerebral Vasospasm following Aneurysmal Subarachnoid Hemorrhage
por: Mehta, Vivek, et al.
Publicado: (2013) -
Minocycline protects against delayed cerebral ischemia after subarachnoid hemorrhage via matrix metalloproteinase‐9 inhibition
por: Vellimana, Ananth K., et al.
Publicado: (2017) -
Post-transcriptional inactivation of matrix metalloproteinase-12 after focal cerebral ischemia attenuates brain damage
por: Chelluboina, Bharath, et al.
Publicado: (2015) -
Enhanced cerebrovascular expression of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 via the MEK/ERK pathway during cerebral ischemia in the rat
por: Maddahi, Aida, et al.
Publicado: (2009)